Sellogen DFL
169799-82-0
|
Cefquinome
84957-30-2
|
Cefpirome sulfate
98753-19-6
|
SK 28501
7799-33-9
|
sephacryl(r) s-300-hr, for chromato- graphy*
82785-74-8
|
Mast Cell Degranulating (MCD) Peptide HR-1
80533-94-4
|
Mast Cell Degranulating (MCD) Peptide HR-2
80388-04-1
|
Glenvastatin
122254-45-9
|
Cefquinome sulfate
123766-80-3
|
1H-Pyrrolo[2,3-c]pyridine-4-carboxylic acid hydrochloride
2228833-06-3
|
rac-5-[(4aR,7aS)-octahydrocyclopenta[b][1,4]oxazine-4-carbonyl]-2-hydroxy-3-methylbenzaldehyde
2248880-85-3
|
3-Amino-3-cyclopropyl-2,2-difluoropropan-1-ol
1337503-55-5
|
2-Cyclobutanecarbonylbutanal
1878050-73-7
|
(3,3-Dimethyloxan-2-yl)methanamine
2167800-89-5
|
N-(3,5-dimethoxyphenyl)-2-(5-oxo-4,5,6,7-tetrahydro[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)acetamide
1210912-96-1
|
1-(2-Methylcyclopropanecarbonyl)pyrrolidine-3-sulfonyl fluoride
2248742-11-0
|
1-(Oxane-4-carbonyl)pyrrolidine-3-sulfonyl fluoride
2249470-49-1
|
1-(2-Methylcyclopropanecarbonyl)piperidine-4-sulfonyl fluoride
2249292-76-8
|
6-(Difluoromethyl)-N-[3-[methyl(prop-2-ynyl)amino]propyl]pyrimidine-4-carboxamide
2249380-78-5
|
